Press Releases

Press Releases

    Date Title View
    10/26/09
    Summary ToggleHorizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
    10/21/09
    Summary ToggleAGA Institute and Horizon Therapeutics Expand CONNECT to Protect Program to Educate Consumers on NSAID Risk
    06/29/09
    Summary ToggleHorizon Therapeutics Names Dr. Jeffery W. Sherman Executive Vice President and Chief Medical Officer
    06/01/09
    Summary ToggleHorizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients with Mild-to-Moderate Pain
    05/01/09
    Summary ToggleAGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated with NSAID Use
    04/14/09
    Summary ToggleNitec Announces First Launch of LODOTRA® In Germany
    01/07/09
    Summary ToggleNitec Pharma's New Rheumatoid Arthritis Treatment,LODOTRA™, Recommended for European Regulatory Approval
    01/06/09
    Summary ToggleHorizon Therapeutics Announces Senior Management Appointments